Showing results (441-450 of 845) with videos related to

Sort By:
Pageof 85
Sexual Health|September 6, 2008
Sexually transmissible infection management practices among primary care physicians in SingaporeRoy K W Chan, Hiok Hee Tan, Martin T W Chio, et al.
Current Oncology (Toronto, Ont.)|April 6, 2013
Cost-effectiveness of systemic therapies for metastatic pancreatic cancerV C Tam, Y J Ko, N Mittmann, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 15, 2017
Cost-Effectiveness Analysis of Systemic Therapies in Advanced Pancreatic Cancer in the Canadian Health Care SystemDoug Coyle, Yoo-Joung Ko, Kathryn Coyle, et al.
Journal of the American College of Cardiology|November 7, 1999
Beta-blockade in heart failure: a comparison of carvedilol with metoprololJ E Sanderson, S K Chan, G Yip, et al.
Current Oncology (Toronto, Ont.)|November 12, 2019
Cost-effectiveness analysis of selective first-line use of biologics for unresectable RAS wild-type left-sided metastatic colorectal cancerW W L Wong, M Zargar, S R Berry, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|December 3, 2002
Use of the low-dose corticotropin stimulation test for the diagnosis of secondary adrenocortical insufficiencyC H Choi, S C Tiu, C C Shek, et al.
BMC Cancer|November 5, 2022
Primary care utilization for patients with newly diagnosed cancer during the COVID-19 pandemic: a population-based studyYing Ling, Matthew C Cheung, Kelvin K W Chan, et al.
BMC Cancer|October 30, 2021
Cost-effectiveness analysis of first-line treatment with crizotinib in ROS1-rearranged advanced non-small cell lung cancer (NSCLC) in CanadaJaclyn M Beca, Shaun Walsh, Kaiwan Raza, et al.
East Asian Archives of Psychiatry : Official Journal of the Hong Kong College of Psychiatrists = Dong Ya Jing Shen Ke Xue Zhi : Xianggang Jing Shen Ke Yi Xue Yuan Qi Kan|March 30, 2023
Psychosis Related to Baclofen Withdrawal or Overdose: A Systematic ReviewP J J Phu, J C L Looi, P C Nair, et al.
Cancer Medicine|December 1, 2021
Examining the association between oncology drug clinical benefit and the time to public reimbursementSasha Thomson, Louis Everest, Noah Witzke, et al.
Pageof 85